Skip to main content
NCBI home page
International Journal of Experimental Pathology logoLink to International Journal of Experimental Pathology
. 1993 Dec;74(6):615–626.

Cyclosporine-induced nephrotoxicity in deoxycorticosterone-NaCl treated rats.

J M Wyss 1, M S Mozaffari 1, P L St John 1, D R Abrahamson 1
PMCID: PMC2002256  PMID: 8292559

Abstract

This study tested the hypothesis that the adverse effects of cyclosporine (Cy) are accelerated in animals with induced hypertension. Four groups of rats were unilaterally nephrectomized at 5 weeks of age. Two weeks later, two of these groups received implantations of Silastic strips impregnated with deoxycorticosterone acetate (DOCA) and were maintained on 1% saline (DOCA-NaCl); the other two groups served as sham controls. Daily injections of Cy (20 mg/kg) were given to one DOCA-NaCl and one control group. During the initial 3 days, the Cy/DOCA-NaCl treated rats displayed a significant increase in systolic arterial pressure (SAP), but their SAP did not increase significantly thereafter. Cy/DOCA-NaCl treatment caused severe nephrotoxicity 18 days after initiation of treatment, but neither cyclosporine nor DOCA-NaCl treatment alone resulted in morphological renal damage. In Cy/DOCA-NaCl rats, the interstitial spaces between renal tubules were dramatically increased in size and contained abundant bundles of collagenous fibres, deposits of immunoreactive laminin, and infiltrates of mononuclear cells. In a second experiment, bilateral renal denervation prior to treatment did not lessen the Cy-induced renal damage. These results indicate that in the DOCA-NaCl rat, Cy treatment damages the renal cortex in a pattern similar to that observed in humans treated chronically with Cy. Further, the results indicate that an absence of renal innervation does not decrease the nephrotoxic effects of Cy in this rapid onset model.

Full text

PDF
615

Images in this article

619Figure 3
on p.619
620Figure 4
on p.620
621Figure 5
on p.621
622Figure 6
on p.622

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abrahamson D. R., Caulfield J. P. Proteinuria and structural alterations in rat glomerular basement membranes induced by intravenously injected anti-laminin immunoglobulin G. J Exp Med. 1982 Jul 1;156(1):128–145. doi: 10.1084/jem.156.1.128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bartold P. M., Hay S., Vernon-Roberts B. Effect of cyclosporine-A on connective tissue deposition in experimental inflammatory lesions. Matrix. 1989 Aug;9(4):293–300. doi: 10.1016/s0934-8832(89)80005-8. [DOI] [PubMed] [Google Scholar]
  3. Borel J. F., Feurer C., Gubler H. U., Stähelin H. Biological effects of cyclosporin A: a new antilymphocytic agent. Agents Actions. 1976 Jul;6(4):468–475. doi: 10.1007/BF01973261. [DOI] [PubMed] [Google Scholar]
  4. Brooks D. P., Drutz D. J., Ruffolo R. R., Jr Prevention and complete reversal of cyclosporine A-induced renal vasoconstriction and nephrotoxicity in the rat by fenoldopam. J Pharmacol Exp Ther. 1990 Aug;254(2):375–379. [PubMed] [Google Scholar]
  5. Brown Z., Neild G. H., Willoughby J. J., Somia N. V., Cameron S. J. Increased factor VIII as an index of vascular injury in cyclosporine nephrotoxicity. Transplantation. 1986 Aug;42(2):150–153. doi: 10.1097/00007890-198608000-00009. [DOI] [PubMed] [Google Scholar]
  6. Capasso G., Rosati C., Ciani F., Giordano D. R., Russo F., De Santo N. G. The beneficial effect of atrial natriuretic peptide on cyclosporine nephrotoxicity. Am J Hypertens. 1990 Mar;3(3):204–210. doi: 10.1093/ajh/3.3.204. [DOI] [PubMed] [Google Scholar]
  7. Chapman J. R., Griffiths D., Harding N. G., Morris P. J. Reversibility of cyclosporin nephrotoxicity after three months' treatment. Lancet. 1985 Jan 19;1(8421):128–130. doi: 10.1016/s0140-6736(85)91902-6. [DOI] [PubMed] [Google Scholar]
  8. Chapman J. R., Marcen R., Arias M., Raine A. E., Dunnill M. S., Morris P. J. Hypertension after renal transplantation. A comparison of cyclosporine and conventional immunosuppression. Transplantation. 1987 Jun;43(6):860–864. [PubMed] [Google Scholar]
  9. Chen Y. F., Nagahama S., Winternitz S. R., Oparil S. Hyperresponsiveness of monoaminergic mechanisms in DOCA/NaCl hypertensive rats. Am J Physiol. 1985 Jul;249(1 Pt 2):H71–H79. doi: 10.1152/ajpheart.1985.249.1.H71. [DOI] [PubMed] [Google Scholar]
  10. Curtis J. J., Luke R. G., Jones P., Diethelm A. G., Whelchel J. D. Hypertension after successful renal transplantation. Am J Med. 1985 Aug;79(2):193–200. doi: 10.1016/0002-9343(85)90009-9. [DOI] [PubMed] [Google Scholar]
  11. Curtis J. J., Luke R. G., Whelchel J. D., Diethelm A. G., Jones P., Dustan H. P. Inhibition of angiotensin-converting enzyme in renal-transplant recipients with hypertension. N Engl J Med. 1983 Feb 17;308(7):377–381. doi: 10.1056/NEJM198302173080707. [DOI] [PubMed] [Google Scholar]
  12. Galle J., Schenck I., Schollmeyer P., Wanner C. Cyclosporine and oxidized lipoproteins affect vascular reactivity. Influence of the endothelium. Hypertension. 1993 Mar;21(3):315–321. doi: 10.1161/01.hyp.21.3.315. [DOI] [PubMed] [Google Scholar]
  13. Gazdar A. F., Dammin G. J. Neural degeneration and regeneration in human renal transplants. N Engl J Med. 1970 Jul 30;283(5):222–224. doi: 10.1056/NEJM197007302830502. [DOI] [PubMed] [Google Scholar]
  14. Gerkens J. F. Cyclosporine treatment of normal rats produces a rise in blood pressure and decreased renal vascular responses to nerve stimulation, vasoconstrictors and endothelium-dependent dilators. J Pharmacol Exp Ther. 1989 Sep;250(3):1105–1112. [PubMed] [Google Scholar]
  15. Gillum D. M., Truong L., Tasby J., Suki W. N. Effects of uninephrectomy and high protein feeding in cyclosporine nephropathy. Kidney Int. 1989 Aug;36(2):194–200. doi: 10.1038/ki.1989.179. [DOI] [PubMed] [Google Scholar]
  16. Grant D., Wall W., Duff J., Stiller C., Ghent C., Keown P. Adverse effects of cyclosporine therapy following liver transplantation. Transplant Proc. 1987 Aug;19(4):3463–3465. [PubMed] [Google Scholar]
  17. Klintmalm G., Bohman S. O., Sundelin B., Wilczek H. Interstitial fibrosis in renal allografts after 12 to 46 months of cyclosporin treatment: beneficial effect of low doses in early post-transplantation period. Lancet. 1984 Oct 27;2(8409):950–954. doi: 10.1016/s0140-6736(84)91166-8. [DOI] [PubMed] [Google Scholar]
  18. Kon V., Sugiura M., Inagami T., Harvie B. R., Ichikawa I., Hoover R. L. Role of endothelin in cyclosporine-induced glomerular dysfunction. Kidney Int. 1990 Jun;37(6):1487–1491. doi: 10.1038/ki.1990.139. [DOI] [PubMed] [Google Scholar]
  19. Kopp J. B., Klotman P. E. Cellular and molecular mechanisms of cyclosporin nephrotoxicity. J Am Soc Nephrol. 1990 Aug;1(2):162–179. doi: 10.1681/ASN.V12162. [DOI] [PubMed] [Google Scholar]
  20. LeGrue S. J., Turner R., Weisbrodt N., Dedman J. R. Does the binding of cyclosporine to calmodulin result in immunosuppression? Science. 1986 Oct 3;234(4772):68–71. doi: 10.1126/science.3749892. [DOI] [PubMed] [Google Scholar]
  21. Lemmi C. A., Pelikan P. C., Sikka S. C., Hirschberg R., Geesaman B., Miller R. L., Park K. S., Liu S. C., Koyle M., Rajfer J. Cyclosporine augments renal mitochondrial function in vivo and reduces renal blood flow. Am J Physiol. 1989 Nov;257(5 Pt 2):F837–F841. doi: 10.1152/ajprenal.1989.257.5.F837. [DOI] [PubMed] [Google Scholar]
  22. Lentino J. R., Rytel M. W., Davis J. P. Serologic evidence of noninvasive nature of Staphylococcus aureus infection in the toxic-shock syndrome. N Engl J Med. 1981 Sep 10;305(11):641–642. doi: 10.1056/NEJM198109103051112. [DOI] [PubMed] [Google Scholar]
  23. Moran M., Tomlanovich S., Myers B. D. Cyclosporine-induced chronic nephropathy in human recipients of cardiac allografts. Transplant Proc. 1985 Aug;17(4 Suppl 1):185–190. [PubMed] [Google Scholar]
  24. Morgan B. J., Lyson T., Scherrer U., Victor R. G. Cyclosporine causes sympathetically mediated elevations in arterial pressure in rats. Hypertension. 1991 Oct;18(4):458–466. doi: 10.1161/01.hyp.18.4.458. [DOI] [PubMed] [Google Scholar]
  25. Moss N. G., Powell S. L., Falk R. J. Intravenous cyclosporine activates afferent and efferent renal nerves and causes sodium retention in innervated kidneys in rats. Proc Natl Acad Sci U S A. 1985 Dec;82(23):8222–8226. doi: 10.1073/pnas.82.23.8222. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Murray B. M., Paller M. S. Beneficial effects of renal denervation and prazosin on GFR and renal blood flow after cyclosporine in rats. Clin Nephrol. 1986;25 (Suppl 1):S37–S39. [PubMed] [Google Scholar]
  27. Murray B. M., Paller M. S., Ferris T. F. Effect of cyclosporine administration on renal hemodynamics in conscious rats. Kidney Int. 1985 Nov;28(5):767–774. doi: 10.1038/ki.1985.196. [DOI] [PubMed] [Google Scholar]
  28. Myers A. K., Canale S., Penhos J. C., Ramwell P. W., Foegh M. L. Preservation of renal compensatory growth in uninephrectomized rats by low-dose cyclosporine. Transplantation. 1990 May;49(5):879–882. doi: 10.1097/00007890-199005000-00008. [DOI] [PubMed] [Google Scholar]
  29. Myers B. D. Cyclosporine nephrotoxicity. Kidney Int. 1986 Dec;30(6):964–974. doi: 10.1038/ki.1986.280. [DOI] [PubMed] [Google Scholar]
  30. Nast C. C., Adler S. G., Artishevsky A., Kresser C. T., Ahmed K., Anderson P. S. Cyclosporine induces elevated procollagen alpha 1 (I) mRNA levels in the rat renal cortex. Kidney Int. 1991 Apr;39(4):631–638. doi: 10.1038/ki.1991.75. [DOI] [PubMed] [Google Scholar]
  31. Palestine A. G., Austin H. A., 3rd, Balow J. E., Antonovych T. T., Sabnis S. G., Preuss H. G., Nussenblatt R. B. Renal histopathologic alterations in patients treated with cyclosporine for uveitis. N Engl J Med. 1986 May 15;314(20):1293–1298. doi: 10.1056/NEJM198605153142005. [DOI] [PubMed] [Google Scholar]
  32. Perico N., Benigni A., Bosco E., Rossini M., Orisio S., Ghilardi F., Piccinelli A., Remuzzi G. Acute cyclosporine A nephrotoxicity in rats: which role for renin-angiotensin system and glomerular prostaglandins? Clin Nephrol. 1986;25 (Suppl 1):S83–S88. [PubMed] [Google Scholar]
  33. Racusen L. C., Solez K. Cyclosporine nephrotoxicity. Int Rev Exp Pathol. 1988;30:107–157. doi: 10.1016/b978-0-12-364930-0.50007-5. [DOI] [PubMed] [Google Scholar]
  34. Ryffel B., Siegl H., Petric R., Muller A. M., Hauser R., Mihatsch M. J. Nephrotoxicity of cyclosporine in spontaneously hypertensive rats: effects on blood pressure and vascular lesions. Clin Nephrol. 1986;25 (Suppl 1):S193–S198. [PubMed] [Google Scholar]
  35. Sabbatini M., De Nicola L., Uccello F., Russo D., Conte G., Dal Canton A., Andreucci V. E. Absence of acute nephrotoxicity with low doses of cyclosporin: experimental study in the rat. Nephrol Dial Transplant. 1990;5(1):69–74. doi: 10.1093/ndt/5.1.69. [DOI] [PubMed] [Google Scholar]
  36. Sabbatini M., Esposito C., Uccello F., De Nicola L., Alba M., Conte G., Dal Canton A., Andreucci V. E. Acute effects of cyclosporine on glomerular dynamics--micropuncture study in the rat. Transplant Proc. 1988 Jun;20(3 Suppl 3):544–548. [PubMed] [Google Scholar]
  37. Scherrer U., Vissing S. F., Morgan B. J., Rollins J. A., Tindall R. S., Ring S., Hanson P., Mohanty P. K., Victor R. G. Cyclosporine-induced sympathetic activation and hypertension after heart transplantation. N Engl J Med. 1990 Sep 13;323(11):693–699. doi: 10.1056/NEJM199009133231101. [DOI] [PubMed] [Google Scholar]
  38. Sripairojthikoon W., Oparil S., Wyss J. M. Renal nerve contribution to NaCl-exacerbated hypertension in spontaneously hypertensive rats. Hypertension. 1989 Aug;14(2):184–190. doi: 10.1161/01.hyp.14.2.184. [DOI] [PubMed] [Google Scholar]
  39. Thiel G., Mihatsch M. J., Stahl R. A., Hermle M., Brunner F. P. Cyclosporine A nephrotoxicity in Goldblatt renovascular hypertension in rats. Clin Nephrol. 1986;25 (Suppl 1):S199–S204. [PubMed] [Google Scholar]
  40. Thompson M. E., Shapiro A. P., Johnsen A. M., Itzkoff J. M., Hardesty R. L., Griffith B. P., Bahnson H. T., McDonald R. H., Jr, Hastillo A., Hess M. The contrasting effects of cyclosporin-A and azathioprine on arterial blood pressure and renal function following cardiac transplantation. Int J Cardiol. 1986 May;11(2):219–229. doi: 10.1016/0167-5273(86)90181-6. [DOI] [PubMed] [Google Scholar]
  41. Thomson S. C., Tucker B. J., Gabbai F. B., Blantz R. C. Glomerular hemodynamics and alpha 2-adrenoreceptor stimulation: the role of renal nerves. Am J Physiol. 1990 Jan;258(1 Pt 2):F21–F27. doi: 10.1152/ajprenal.1990.258.1.F21. [DOI] [PubMed] [Google Scholar]
  42. Versluis D. J., Ten Kate F. J., Wenting G. J., Jeekel J., Weimar W. Histological lesions associated with cyclosporin: incidence and reversibility in one year old kidney transplants. J Clin Pathol. 1988 May;41(5):498–503. doi: 10.1136/jcp.41.5.498. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Wells M. S., Vogelsang G. B., Colombani P. M., Hess A. D. Cyclosporin A binding to calmodulin. Transplant Proc. 1989 Feb;21(1 Pt 1):850–852. [PubMed] [Google Scholar]
  44. Xue H., Bukoski R. D., McCarron D. A., Bennett W. M. Induction of contraction in isolated rat aorta by cyclosporine. Transplantation. 1987 May;43(5):715–718. doi: 10.1097/00007890-198705000-00022. [DOI] [PubMed] [Google Scholar]

Articles from International Journal of Experimental Pathology are provided here courtesy of Wiley

RESOURCES